214 related articles for article (PubMed ID: 6253060)
1. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
Armstrong RD; Diasio RB
Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
Armstrong RD; Diasio RB
Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cytotoxic activity of 5'-deoxy-5-fluorouridine.
Armstrong RD; Connolly KM; Kaplan AM; Cadman E
Cancer Chemother Pharmacol; 1983; 11(2):102-5. PubMed ID: 6226452
[TBL] [Abstract][Full Text] [Related]
4. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
6. Role of administration route in the therapeutic efficacy of doxifluridine.
Trave F; Canobbio L; Au JL; Rustum YM
J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
[TBL] [Abstract][Full Text] [Related]
7. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
Takimoto CH; Cadman EC; Armstrong RD
Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of 5'-deoxy-5-fluorouridine in patients with resistant ovarian cancer.
de Bruijn EA; van Oosterom AT; Tjaden UR; Reeuwijk HJ; Pinedo HM
Cancer Res; 1985 Nov; 45(11 Pt 2):5931-5. PubMed ID: 2932219
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humans.
Sommadossi JP; Aubert C; Cano JP; Gouveia J; Ribaud P; Mathé G
Cancer Res; 1983 Feb; 43(2):930-3. PubMed ID: 6216947
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil.
Ajmera S; Bapat AR; Stephanian E; Danenberg PV
J Med Chem; 1988 Jun; 31(6):1094-8. PubMed ID: 2967375
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of 5'-deoxy-5-fluorouridine in cultured human tumors.
Armstrong RD; Gesmonde J; Wu T; Cadman E
Cancer Treat Rep; 1983 Jun; 67(6):541-5. PubMed ID: 6222789
[TBL] [Abstract][Full Text] [Related]
12. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.
Armstrong RD; Cadman E
Cancer Res; 1983 Jun; 43(6):2525-8. PubMed ID: 6221792
[TBL] [Abstract][Full Text] [Related]
13. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine (capecitabine).
Ishikawa T; Fukase Y; Yamamoto T; Sekiguchi F; Ishitsuka H
Biol Pharm Bull; 1998 Jul; 21(7):713-7. PubMed ID: 9703255
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine.
Miwa M; Ishikawa T; Eda H; Ryu M; Fujimoto K; Ninomiya Y; Umeda I; Yokose K; Ishitsuka H
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):998-1003. PubMed ID: 2143107
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
Ikemoto S; Sugimura K; Wada S; Yasumoto R; Yamamoto K; Kishimoto T
Cancer Lett; 1999 Oct; 145(1-2):121-6. PubMed ID: 10530779
[TBL] [Abstract][Full Text] [Related]
17. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha and 5'-deoxy-5-fluorouridine in colon cancer: effects as single agents and in combination on growth of xenograft tumours.
Laurent PL; Tevaearai HT; Eliason JF; Givel JC; Odartchenko N
Eur J Cancer; 1994; 30A(12):1859-65. PubMed ID: 7880618
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
Grant S; Cadman E
Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
[TBL] [Abstract][Full Text] [Related]
20. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]